Call Us Contact Us
+44 1494 818 000     Online Enquiry
Lines open
Monday to Thursday
08:30 to 18:00
Friday
08:30 to 17:30
Pharmaceutical | Medical Devices | Scientific | Consumer Healthcare | Dental | Animal Health | FMCG | Executive
         
Latest Jobs
Exclusive vacancies may not be shown here, please contact Phil on +44 1494 818008 or phil@zenopa.com for more information.
Have you registered?
Once you register you can see additional job details, save jobs, track your applications and manage e-lert preferences.

Register now
Phil Hardy
Account Manager
phil@zenopa.com
+44 1494 818008

Testimonials
It has been a great experience working with a company that really cares. Zenopa have been so brilliant all the way, the support they gave me has been first class.
Mechell, 2012

Medtronic accepts terms of preliminary injunction

30 June 2009 00:00 in Medical Company Product News


Medtronic has accepted the terms of an order that mean a company will not be able to use misleading marketing claims related to its Kyphon Balloon Kyphoplasty.

On May 19th, the German competition court granted the company a preliminary injunction against DFine Europe.

As part of the order, the firm is to no longer use certain promotional claims that compare its bone StabiliT ER2 to Medtronic's KyphX HV-R Bone Cement.

DFine Europe has also agreed to the terms.

Under German law, a preliminary injunction is given as an action against anti-competitive behaviour, which includes illegal advertising.

Meanwhile, the Food and Drug administration has granted Physio-Control ? a wholly-owned subsidiary of Medtronic - marketing clearance for its next-generation Lucas Chest Compression.

The device is an automated item that gives consistent treatment to victims in cardiac arrest, without any interruptions.

President of Physio-Control Brian Webster said the product was in response to customers who had been asking for a battery-operated version of the Lucas over the last couple of years.

Other news stories from 30/06/2009

Related news

Read more in the Zenopa News Archive

How this news is generated

Story collated for Zenopa by the Adfero News Agency



             
© Copyright 2013 Zenopa Ltd